Carnegie Mellon University
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 5, 2025), Carnegie Mellon University reported 6 stock positions worth $129.0 million. Its top holding was Duolingo (DUOL) at 74.6% of the portfolio, followed by Invesco QQQ Trust Series 1 (QQQ, 22.2%) and PDD (PDD, 3.2%). Compared with Q4 2024, it added to 1 and reduced 1. The biggest buy was Invesco QQQ Trust Series 1 (QQQ, shares +0%) and the biggest sale Duolingo (DUOL, shares −2%).
- Most Recent 13F
- Q2 2026
- Location
- Pittsburgh, PA
- CIK
- 0001039067
- Portfolio Value
- $129.0M (Q1 2025)
- SEC Filing
- 0000898432-25-000312 ↗ filed May 5, 2025
Holdings Value
Holdings 6 stocks · $129.0M
| DUOL Duolingo | 74.57% | 309,814 | $96.2M | Reduce -1.6% |
| QQQ Invesco QQQ Trust Series 1 | 22.15% | 60,947 | $28.6M | Add +0.2% |
| PDD PDD Holdings Inc. | 3.24% | 35,322 | $4.2M | No change |
| IHT Innsuites Hospitality Trust | 0.02% | 10,000 | $23K | No change |
| LONGEVITY HEALTH HLDGS INC | 0.01% | 134,469 | $17K | No change |
| PREDICTIVE ONCOLOGY INC | 0.01% | 10,358 | $16K | No change |
Portfolio Sells Q4 2024 → Q1 2025
| DUOL Duolingo | Reduce -1.6% | 74.57% | −0.12 |
Portfolio Buys Q4 2024 → Q1 2025
| QQQ Invesco QQQ Trust Series 1 | Add +0.2% | 22.15% | −0.61 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $78.9M | QQQ, DUOL, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q1 2026 | 5 | $64.3M | QQQ, DUOL, IHT, LONGEVITY HEALTH HLDGS INC, AGPU |
| Q4 2025 | 5 | $89.3M | DUOL, QQQ, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q3 2025 | 5 | $131.6M | DUOL, QQQ, IHT, PREDICTIVE ONCOLOGY INC, LONGEVITY HEALTH HLDGS INC |
| Q2 2025 | 5 | $154.6M | DUOL, QQQ, IHT, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC |
| Q1 2025 | 6 | $129.0M | DUOL, QQQ, PDD, IHT, LONGEVITY HEALTH HLDGS INC |
| Q4 2024 | 6 | $136.7M | DUOL, QQQ, PDD, LONGEVITY HEALTH HLDGS INC, IHT |
| Q3 2024 | 4 | $96.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q2 2024 | 4 | $73.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q1 2024 | 6 | $80.1M | DUOL, VERA, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC, NBSE |